John A. Ward

Array ( [id] => 7341126 [patent_doc_number] => 20040191173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Metastasis models using green fluorescent protein (GFP) as a marker' [patent_app_type] => new [patent_app_number] => 10/820081 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7451 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191173.pdf [firstpage_image] =>[orig_patent_app_number] => 10820081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 390056 [patent_doc_number] => 07300651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-27 [patent_title] => 'Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1' [patent_app_type] => utility [patent_app_number] => 10/819493 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 15052 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/300/07300651.pdf [firstpage_image] =>[orig_patent_app_number] => 10819493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276321 [patent_doc_number] => 20040235772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'DNA expression construct for the treatment of infections with leishmaniasis' [patent_app_type] => new [patent_app_number] => 10/816591 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6783 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235772.pdf [firstpage_image] =>[orig_patent_app_number] => 10816591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276320 [patent_doc_number] => 20040235771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Means for eliciting an immune response and a method therefor' [patent_app_type] => new [patent_app_number] => 10/816465 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9185 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235771.pdf [firstpage_image] =>[orig_patent_app_number] => 10816465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9238673 [patent_doc_number] => 08603462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction' [patent_app_type] => utility [patent_app_number] => 10/551317 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13912 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10551317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921612 [patent_doc_number] => 20060240114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Drug for treating hemophilia and method of treating hemophilia using the same' [patent_app_type] => utility [patent_app_number] => 10/549555 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4301 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240114.pdf [firstpage_image] =>[orig_patent_app_number] => 10549555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675783 [patent_doc_number] => 20040154044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Transgenic cell and animal modeling ige-mediated human allergic responses and use thereof' [patent_app_type] => new [patent_app_number] => 10/472050 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11985 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20040154044.pdf [firstpage_image] =>[orig_patent_app_number] => 10472050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7318838 [patent_doc_number] => 20040224888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Use of cardiotrophin in liver diseases' [patent_app_type] => new [patent_app_number] => 10/798219 [patent_app_country] => US [patent_app_date] => 2004-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8525 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224888.pdf [firstpage_image] =>[orig_patent_app_number] => 10798219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469828 [patent_doc_number] => 20040121304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligands' [patent_app_type] => new [patent_app_number] => 10/250400 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12581 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121304.pdf [firstpage_image] =>[orig_patent_app_number] => 10250400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7345768 [patent_doc_number] => 20040247662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Systemic immune activation method using nucleic acid-lipid complexes' [patent_app_type] => new [patent_app_number] => 10/780114 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 29674 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247662.pdf [firstpage_image] =>[orig_patent_app_number] => 10780114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7238461 [patent_doc_number] => 20040157792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Controlling immune response to specific antigens' [patent_app_type] => new [patent_app_number] => 10/776119 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14636 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157792.pdf [firstpage_image] =>[orig_patent_app_number] => 10776119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8082551 [patent_doc_number] => 08148600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Immunocompromised rodents as dual color tumor models' [patent_app_type] => utility [patent_app_number] => 10/775554 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5104 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148600.pdf [firstpage_image] =>[orig_patent_app_number] => 10775554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7238446 [patent_doc_number] => 20040157791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Systemic immune activation method using nucleic acid-lipid complexes' [patent_app_type] => new [patent_app_number] => 10/772913 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 28031 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157791.pdf [firstpage_image] =>[orig_patent_app_number] => 10772913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304509 [patent_doc_number] => 20040115803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Transgenic cells and animals for the study of the polarization of the immune response' [patent_app_type] => new [patent_app_number] => 10/471465 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11329 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115803.pdf [firstpage_image] =>[orig_patent_app_number] => 10471465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7461845 [patent_doc_number] => 20040197903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Method for induction of proliferation of natural killer cells by dendritic cells cultured with GM-CSF and IL-15' [patent_app_type] => new [patent_app_number] => 10/770257 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11084 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197903.pdf [firstpage_image] =>[orig_patent_app_number] => 10770257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264986 [patent_doc_number] => 20040242522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Polynucleotide vaccine formulations' [patent_app_type] => new [patent_app_number] => 10/764921 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18147 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242522.pdf [firstpage_image] =>[orig_patent_app_number] => 10764921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250057 [patent_doc_number] => 20050142120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Cells expressing anti-Fc receptor binding components' [patent_app_type] => utility [patent_app_number] => 10/764131 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17031 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142120.pdf [firstpage_image] =>[orig_patent_app_number] => 10764131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7438863 [patent_doc_number] => 20040231012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Murine expression of human IgA Lambda locus' [patent_app_type] => new [patent_app_number] => 10/753554 [patent_app_country] => US [patent_app_date] => 2004-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9790 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20040231012.pdf [firstpage_image] =>[orig_patent_app_number] => 10753554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7294976 [patent_doc_number] => 20040213786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Compositions and methods for treating T-cell mediated autoimmune diseases' [patent_app_type] => new [patent_app_number] => 10/749515 [patent_app_country] => US [patent_app_date] => 2004-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13503 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20040213786.pdf [firstpage_image] =>[orig_patent_app_number] => 10749515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7286643 [patent_doc_number] => 20040146856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Anti-neoplastic viral agents' [patent_app_type] => new [patent_app_number] => 10/433681 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8570 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146856.pdf [firstpage_image] =>[orig_patent_app_number] => 10433681 [rel_patent_id] =>[rel_patent_doc_number] =>)